Surgery (Limb-Sparing Resection/Amputation)

Treatment for Malignant Neoplasm Of Bone And Articular Cartilage

Effectiveness
95%
Safety Score
50%
Clinical Trials
1,000
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate (tumor removal), 3-12 months for recovery/rehabilitation
Treatment Duration
Single procedure, followed by rehabilitation for months to years
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$15,000
Side Effect Mgmt:$20,000
Total Annual:$35,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
4.5
Outcome-Based Costs
Cost per Responder
$37,368
Cost per Remission
$39,444
Surgery (Limb-Sparing Resection/Amputation) Outcomes

for Malignant Neoplasm Of Bone And Articular Cartilage

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+90%
Common Side Effects
Infection
+10%
Bleeding/Hematoma
+7%
Nerve damage/Neuropathy
+10%
Post-operative pain
+35%
Implant failure/Loosening (for prostheses)
+7%
Loss of function/mobility
+20%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov